Resources Contact Us Home
43 Kd protein vaccine and method for the production thereof

Image Number 5 for United States Patent #5543304.

A protein derivable from Actinobacillus pleuropneumoniae (APP) having a molecular size ranging between 43 Kd on SDS PAGE is described. The protein is soluble on sodium lauryl sarcosinate (SLS) and not heat modifiable. The protein can also be derived by recombinant methods. The protein in a vaccine provides immunity against multiple serotypes of APP.

  Recently Added Patents
Cooling structure for electronic device
Concentrating photovoltaic system module with actuator control
Connector with shielding device and method for manufacturing connector
Battery pouch sheet edge insulation
Electronic device with embedded antenna
Process for preparing substituted aromatic carboxylic acids
  Randomly Featured Patents
Opening/closing valve
Method and apparatus for measurement of unsteady gas temperatures
Methods and compositions for improved F-18 labeling of proteins, peptides and other molecules
Specimen collection kit for mailing and method of using same
Hay bale spike assembly
Chain sheath
Oxidized thioether derivatives
Wiring structure of semiconductor device and method for manufacturing the same
Quinolone derivatives
Hyperpolarized gas containers,solenoids, transport and storage devices and associated transport and storage methods